In October 2023, Sanofi announced plans to separate its consumer health unit in 2024. Sanofi’s consumer health division, with ...

Buyout firm Advent International is considering the sale of generic drugmaker Zentiva, in a deal that could value the former Sanofi unit at about €5 billion ($5.4 billion), according to people ...

Multinational medical companies reached collaborations with local healthcare authorities, hospitals and businesses at the ongoing 7th China International Import Expo held in Shanghai to jointly build ...

Pharmaceutical M&A came back with a bang during October, after a quiet September. Merck & Co (NYSE: MRK) and AbbVie (NYSE: ...

In September, the use of a Sanofi immuno-inflammatory medicine to ... It said personalized nutrition consultancy and smart ...

Fitch Solutions has predicted that the naira would slide to as low as N1,993 per dollar in 2028, severely impacting Nigeria’s ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

Dr Reddy's expects overall sales to grow in double digits, with branded business in India and emerging markets growing in ...

While Bayer and Sanofi have a consumer health presence, they are busy absorbing Monsanto and Boehringer Ingelheim’s consumer businesses respectively and may be less likely to bid. [caption id ...

BMI has predicted that naira will reach N1,993/$ by 2028, impacting Nigeria’s pharmaceutical industry’s ability to import ...